Pharmacoepidemiology and Drug Safety

Article	Citations
Social media for early characterization of pandemic symptoms: A qualitative analysis of patient‐reported COVID‐19 experiences	64
Issue Information	51
Real‐World Evidence of Indapamide‐Induced Rhabdomyolysis: A Retrospective Analysis of Electronic Health Records	44
Data Resource Profile: The Danish National Hospital Medicine Register	43
Use patterns of systemic immunomodulators in the United States before and after dupilumab approval in adults with atopic dermatitis	35
Validity of inpatient electronic health record‐based measures of oxygen‐related therapy in the United States: Lessons applicable for studying COVID‐19 endpoints	31
Predictors of Potentially Inappropriate Stimulant Prescribing Among Adults	28
INSIGHT: A Tool for Fit‐for‐Purpose Evaluation and Quality Assessment of Standardized Observational Data Sources for Real World Evidence on Medicine and Vaccine Safety	28
Success of the German Cystic Fibrosis Registry	27
Use of Causal Framework to Evaluate Effect of Abuse Deterrent Properties of Extended‐Release Oxycodone on Tampering in a Real‐World Settings	26
	26
Stability of individual dementia diagnoses in routine care: Implications for epidemiological studies	24
Identifying frequent drug combinations associated with delirium in older adults: Application of association rules method to a case‐time‐control design	24
	23
Optimizing therapeutic decision‐making for off‐label medicines use: A scoping review and consensus recommendations for improving practice and research+	23
Issue Information	23
Joint longitudinal trajectories of pain intensity and opioid prescription in veterans with back pain	22
Delayed pregnancy detection and return to fertility with extended levonorgestrel‐containing oral contraceptives: A real world setting cohort study	22
	21
A cross‐sectional survey to evaluate prescribers' knowledge and understanding of safety messages following Dengvaxia® product information update	20
Development and validation of case‐finding algorithms to identify prosthetic joint infections after total knee arthroplasty in Veterans Health Administration data	19
Cinacalcet and gastrointestinal bleeding risk in patients receiving hemodialysis	19
Heterogeneity after harmonisation: A retrospective cohort study of bleeding and stroke risk after the introduction of direct oral anticoagulants in four Western European countries	18
Validation of diagnosis codes for chorioamnionitis in medical encounter data, 2013–2018	18
Prescriber perceptions of boxed warnings: A qualitative study	18

Issue Information	17
Overview of the European post‐authorisation study register post‐authorization studies performed in Europe from September 2010 to December 2018	16
The use of uncertain exposure—A method to define switching and add‐on in pharmacoepidemiology	15
Antifungal medication use during pregnancy and the risk of selected major birth defects in the National Birth Defects Prevention Study, 1997–2011	15
Issue Information	15
Using multiple random index dates with the reverse waiting time distribution improves precision of estimated prescription durations	15
	15
External validity in distributed data networks	14
Sampling in the case‐time‐control design among drug users when outcome prevents further treatment	14
Abstracts of ICPE 2023, the 39th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Halifax, Canada, 25–27 August 2023	14
Validation of coding algorithms for the identification of herpes zoster among children	13
Hepatitis B vaccine and risk of acute myocardial infarction among individuals with diabetes mellitus	13
Issue Information	13
	13
The use of narrative electronic prescribing instructions in pharmacoepidemiology: A scoping review for the International Society for Pharmacoepidemiology	13
AfRIG 2021 Virtual Meeting	13
Validity of self‐reports of medication treatment of depression in general population surveys	13
An observational post‐authorization safety study (PASS) of naloxegol drug utilization in four European countries	12
Correlation of drug dose estimated from national prescription registers with mean blood level of antiseizure medication in pregnancy	12
Development and validation of case‐finding algorithms to identify acute pancreatitis in the Veterans Health Administration	12
Issue Information	12
The impact of more restrictive hydrocodone rescheduling on unintentional pediatric opioid exposures	12
Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults	12
Impact of direct‐acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers	12
A feasibility assessment of real‐world data capabilities for monitoring vaccine safety and effectiveness in China: Human papillomavirus vaccination in the Yinzhou district as a use case	12
Quality of rheumatoid arthritis recording in United Kingdom Clinical Practice Research Datalink Aurum	11
The impact of regulatory restrictions on pregabalin use in Saudi Arabia: An interrupted time series analysis	11
To wait or not to wait: Weighing the pros and cons of early identification of safety concerns for medications used in pregnancy	11
Sex disparities in treatment patterns after metformin initiation among patients with type 2 diabetes mellitus	11
Landscape review of global real‐world data sources for studying medication use in pregnancy and lactation that support regulatory decision making	11
Assessing heterogeneity of electronic health‐care databases: A case study of background incidence rates of venous thromboembolism	11
Issue Information	10
SUPPLEMENTARY ABSTRACTS of ICPE 2021, the 37th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), 23–25 August, 2021 (virtual)	10
Association of Pharmacist Interventions With Adverse Drug Events and Potential Adverse Drug Events	10
A strategy for assessment and validation of major bleeding cases in a primary health care database in Spain	10
Identification of risk factors for adverse drug reactions in a pharmacovigilance database	10
	10
Issue Information	10
Examining the potential direct cardiovascular benefit of tumor‐necrosis factor inhibitor in rheumatoid arthritis: Natural and controlled direct effect analyses	10
	10
Issue Information	9
Issue Information	9
Validation of serostatus of rheumatoid arthritis using ICD‐10 codes in administrative claims data	9
Effect of the combination of diuretics, renin–angiotensin–aldosterone system inhibitors, and non‐steroidal anti‐inflammatory drugs or metamizole (triple whammy) on hospitalisation due to acute kidney	9
STUDENT ABSTRACTS of ISPE's 2023 Mid‐Year Meeting, Reykjavik, Iceland, 23–25 April 2023	9
Transparency of high‐dimensional propensity score analyses: Guidance for diagnostics and reporting	9
Sex differences in the utilization of drugs for COVID‐19 treatment among elderly residents in a sample of Italian nursing homes	9
A descriptive analysis of postmarketing requirement studies and clinical trials	9
Use of intravenous iron and risk of anaphylaxis: A multinational observational post‐authorisation safety study in Europe	9
Machine learning for improving high‐dimensional proxy confounder adjustment in healthcare database studies: An overview of the current literature	8

Severe Cutaneous Adverse Reactions in Hospitalized Children: A Pilot Validation Study	8
Core Concepts in Pharmacoepidemiology: New‐User Designs	8
The risk of melanoma with rasagiline compared with other antiparkinsonian medications: A retrospective cohort study in the United States medicare database	8
Methods to refine and extend a Pregnancy Register in the UK Clinical Practice Research Datalink primary care databases	8
Validation of an electronic algorithm for Hodgkin and non‐Hodgkin lymphoma in ICD‐10‐CM	8
Novel methods for pregnancy drug safety surveillance in the FDA Sentinel System	8
Patient Characteristics and Practice Variation Associated With New Community Prescription of Benzodiazepine and z‐Drug Hypnotics After Critical Illness: A Retrospective Cohort Study Using the UK<	8
Linkage of public health and all payer claims data for population‐level opioid research	8
Risk of major congenital malformations associated with first‐trimester exposure to propulsives: A health administrative database study in Japan	8
Emulation of a randomized controlled trial in ulcerative colitis with US and French claims data: Infliximab with thiopurines compared to infliximab monotherapy	8
Validation of diagnosis codes in healthcare databases in Taiwan, a literature review	8
Barriers and Facilitators on Pharmacovigilance Practice Among Pharmacists in Metro Manila, Philippines	8
Identifying inpatient mortality in MarketScan claims data using machine learning	8
Matching study design to prescribing intention: The prevalent new‐user design for studying abuse‐deterrent formulations of opioids	7
ABSTRACTS of ICPE 2022, the 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Copenhagen, Denmark, 26–28 August, 2022	7
Evaluation of more than one billion outpatient prescriptions and eight‐year trend showing a remarkable reduction in antibiotic prescription in Turkey: A success model of governmental interv	7
Predicting obesity and smoking using medication data: A machine‐learning approach	7
Non‐adherence and non‐persistence with antiretroviral treatment in Belgium: A real‐world evaluation using a pharmacy database, 2018–2021	7
Pharmacovigilance network as an additional tool for the surveillance of antimicrobial resistance	7
Management of epilepsy in Lebanon: Medication reviews and drug‐related problems	7
Defining the duration of the dispensation of oral anticoagulants in administrative healthcare databases	7
Prevalence of self‐medication practices among pregnant women in India: A systematic review and meta‐analysis	7
Biases associated with epidermal necrolysis reporting in pharmacovigilance: An exploratory analysis using World Health Organization VigiBase	7
A systematic review of how missing data are handled and reported in multi‐database pharmacoepidemiologic studies	7
Overview of global real‐world data sources for pediatric pharmacoepidemiologic research	7
International trends in prescription opioid sales among developed and developing economies, and the impact of the COVID‐19 pandemic: A cross‐sectional analysis of 66 countries	7
Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark	6
A review of the sampling methodology used in studies evaluating the effectiveness of risk minimisation measures in Europe	6
A data‐informed approach using individualised dispensing patterns to estimate medicine exposure periods and dose from pharmaceutical claims data	6
Issue Information	6
Identifying Patients With Primary Biliary Cholangitis and Cirrhosis Using Administrative Data in a National Cohort	6
Correction to “Effect of tramadol and DOACs with special attention to dabigatran on concomitant use, on the risk of mayor bleeding using BIFAP database in Spain”	6
Rhekiss—The German Register for Child Wish and Pregnancies in Inflammatory Rheumatic Diseases	6
Real world prescription of beta‐blockers in patients with asthma	6
Corrigendum to “Factors of importance for discontinuation of thiazides associated with hyponatremia in Sweden – a population‐based register study”	6
Bias of time‐varying exposure effects due to time‐varying covariate measurement strategies	6
Use of hydrochlorothiazide and risk of skin cancer in a large nested case‐control study in Spain	6
Comparison of the incidence of bleeding between baloxavir marboxil and other anti‐influenza drugs among outpatients with influenza virus infection: A retrospective cohort study using an employment‐bas	6
Monitoring Pregnancies Exposed to Galcanezumab for Migraine in a United States Administrative Claims Database	6
Method used to identify adenomyosis and potentially undiagnosed adenomyosis in a large, U.S. electronic health record database	6
Adapting the European Concerted Action on Congenital Anomalies and Twins (EUROCAT) Guide 1.5 for Use in Post‐Authorisation Safety Studies Using US Data	6
The Awareness of and Adherence to the Pregnancy Prevention Program for Oral Retinoids: A Questionnaire Survey in Denmark	6
Predicting risk of suicidal behavior from insurance claims data vs. linked data from insurance claims and electronic health records	6
Effectiveness of Baricitinib Risk Minimization Activities in Patients With Rheumatoid Arthritis—A Cohort Study in Four Nordic Countries	6
	6
Association between different diabetes medication classes and risk of Parkinson's disease in people with diabetes	6
Mental Health and Medicine Use for Headache: A Nationally Representative Study of Adolescents in Denmark	6
Core Concepts in Pharmacoepidemiology: Quantitative Bias Analysis	6
Quantitative Benefit–Risk Assessment of Vaccination Against COVID‐19: A Systematic Review	6
Cover Image, Volume 33, Issue 8	6
Use of Hydrochlorothiazide in the United States Following Label Update About Skin Cancer Risk	6
Correction to “A data‐informed approach using individualised dispensing patterns to estimate medicine exposure periods and dose from pharmaceutical claims data”	6
	5
Mobile apps for quick adverse drug reaction report: A scoping review	5
A Brief Report on Proposed Areas of International Harmonization of Real‐World Evidence Relevance, Reliability and Quality Standards Among Medical Product Regulators	5
Differential frequency in imaging‐based outcome measurement: Bias in real‐world oncology comparative‐effectiveness studies	5
Antibiotics and Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome: Analysis of Brazilian Pharmacovigilance Registries	5
Incidence and outcomes of adverse drug reactions to first‐line anti‐tuberculosis drugs and their effects on the quality of life: A multicenter prospective cohort study	5
Use of Potentially Nephrotoxic Drugs in Type 2 Diabetes Patients on SGLT2i: A Trajectories Analysis	5
Issue Information	5
Issue Information	5
Initiation of quarterly palmitate paliperidone in French clinical practice: Results from the observational, cross‐sectional OPTIMUS study	5
Comparison of drug prescribing before and during the COVID‐19 pandemic: A cross‐national European study	5
Calculating daily dose in the Observational Medical Outcomes Partnership Common Data Model	5
Mixed Impact of Direct Healthcare Professional Communications When Considering Proximal Outcomes and the Targeted Population: A Systematic Review	5
Control yourself: ISPE‐endorsed guidance in the application of self‐controlled study designs in pharmacoepidemiology	5
Issue Information	5
	5
A new analytic tool for assessing the impact of the US Food and Drug Administration regulatory actions	5
Validation studies of Japanese administrative health care data: A scoping review	5
Effect of Deregulation of the Brazilian National Controlled Products Management System on Antidepressants' Sales Data Deregulation of a Brazilian Drug Electronic System	5
Validation of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Coding in US Claims Data	5
Ten Must‐Read Papers on Transparency and Reproducibility in Pharmacoepidemiology	5
Validity of congenital malformation diagnoses in healthcare claims from a university hospital in Japan	5
Assessing cumulative effects of medication use: New insights and new challenges	5
Moxifloxacin monotherapy for treatment of uncomplicated pelvic inflammatory disease: A systematic review and meta‐analysis with trial sequential analysis of randomized controlled trials	5
Considerations for observational study design: Comparing the evidence of opioid use between electronic health records and insurance claims	5
Dopamine agonists and risk of lung cancer in patients with restless legs syndrome	4
Trends in strong opioid prescribing in Ireland: A repeated cross‐sectional analysis of a national pharmacy claims database between 2010 and 2019	4
Barbro Westerholm, 1933–2023	4

Adverse drug reactions and hospital admissions: Large case‐control study of patients aged 65–100 years using linked English primary care and hospital data	4
Using Quantitative Bias Analysis to Adjust for Misclassification of COVID‐19 Outcomes: An Applied Example of Inhaled Corticosteroids and COVID‐19 Outcomes	4
Evaluating the association between antidepressant dose trajectories and treatment augmentation in pediatric depression	4
A case for screening real‐world data for collateral drug benefits: Glucagon‐like peptide 1 receptor agonists and bile acid diarrhea	4
Signal detection of adverse events associated with gabapentinoid use for chronic pain	4
Risk of ischemic stroke associated with direct oral anticoagulants discontinuation on patients with non‐valvular atrial fibrillation	4
Comment on: Exploring the impact of design criteria for reference sets on performance evaluation of signal detection algorithms: The case of drug–drug interactions	4
	4
Systematically exploring repurposing effects of antihypertensives	4
ISPE MidYear 2021	4
Evaluating an ICD‐10 Based Proxy for Date of Birth in Electronic Health Record Data	4
Trends in antipsychotic use for youth with attention‐deficit/hyperactivity disorder and disruptive behavior disorders	4
A comparison of confounder selection and adjustment methods for estimating causal effects using large healthcare databases	4
Impact of adherence to drugs for secondary prevention on mortality and cardiovascular morbidity: A population‐based cohort study. IMPACT study	4
More Drugs and Fewer Strokes? Time Trends in CVD Medication and Incidence of Stroke With German Health Insurance Data	4
Trajectories of opioid consumption as predictors of patient‐reported outcomes among individuals attending multidisciplinary pain treatment clinics	4
QTc prolongation in COVID‐19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir/ritonavir: A systematic review and meta‐analysis	4
Oral phosphodiesterase type 5 inhibitors and priapism: A VigiBase analysis	4
ABSTRACTS of the virtual 2nd Annual African Regional Interest Group Meeting (AfRIG), 11–13 July, 2022	4
	4
Pharmacoepidemiology and Drug Safety's core concepts in pharmacoepidemiology section at 1 year: Where do we go from here?	4
Understanding the variability of pharmaco‐epidemiological studies assessing the risk of appendicitis with mRNA COVID‐19 vaccines	4
Validity of hospital ICD‐10‐GM codes to identify anaphylaxis	4
Pandemic vaccine testing: Combining conventional and challenge studies	4
Feasibility and validity of using healthcare databases to conduct cross‐national comparative studies of opioid use, its determinants and consequences	4
Profiling real‐world data sources for pharmacoepidemiologic research: A call for papers	4
	4
How to account for early overly small risk sets in the analysis of pregnancy outcome data?—Comparison of different methods for stabilizing the Aalen‐Johansen estimator	4
Beta‐blocker use and survival after pancreatic cancer surgery: A nationwide population‐based cohort study	4
Prescriptions of analgesics during chronic cancer disease trajectories: A complete national cohort study	3
Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Development and Pilot of a Metadata List and Catalogue in Europe	3
Issue Information	3
Nirmatrelvir/Ritonavir (Paxlovid) Use Among Individuals at Risk of Severe COVID‐19: An Analysis of the National COVID Cohort Collaborative (N3C)	3
Record linkage of claims and cancer registries data—Evaluation of a deterministic linkage approach based on indirect personal identifiers	3
Trends in the Completeness and Validity of Sources of Death Data Against the National Death Index From 2010 to 2018	3
Off‐label low dose amitriptyline for insomnia disorder: Patient‐reported outcomes	3
Observed‐over‐Expected analysis as additional method for pharmacovigilance signal detection in large‐scaled spontaneous adverse event reporting	3
Issue Information	3
The role of prenatal exposure to antidepressants, anxiolytic, and hypnotics and its underlying illness on the risk of miscarriage using BIFAP database	3
Issue Information	3
Using Joinpoint regression for drug utilization research: Tutorial and case study of prescription opioid use in the United States	3
Trends in use of proton pump inhibitors among adults in the United States from 1999 to 2018	3
Opioid prescribing and risks among commercially insured women undergoing pelvic organ prolapse repair	3
Uncommon side effects of common drugs in patients with familial dysautonomia	3
Cover Image, Volume 30, Issue 9	3
Adverse Menstrual Events Reported After and Before (or Without) COVID‐19 Vaccination: A Systematic Review and Meta‐Analysis of Comparative Observational Studies	3
Issue Information	3
A Dynamic Prognostic Model for Identifying Vulnerable COVID‐19 Patients at High Risk of Rapid Deterioration	3
Statin (mis)use in older people: A cross‐sectional study using French health insurance databases	3
Validation of a Major and Clinically Relevant Nonmajor Bleeding Phenotyping Algorithm on Electronic Health Records	3
Advancing Research Transparency and Reproducibility in Pharmacoepidemiology	3
Cases of acquired hemophilia A following COVID‐19 vaccines: Cogent safety signal or possible reporting/detection bias? Preliminary evidence from Tuscany, Italy	3
Comparison of characteristics of patients with lung cancer in U.K. primary care databases: Clinical Practice Research Datalink Aurum and GOLD	3
Gout and sodium‐glucose cotransporter‐2 inhibitors	3
Keep Your Guard Up: The Potential Impact of Drug Shortages on Pharmacoepidemiological Studies	3
The Use of Japanese Traditional (Kampo) Medicines Before and During Pregnancy in Japan: The Tohoku Medical Megabank Project Birth and Three‐Generation Cohort Study	3
Issue Information	3
Effect of concomitant antiplatelet therapy on ischemic and hemorrhagic events in patients taking oral anticoagulants for nonvalvular atrial fibrillation in daily clinical practice	3
The FDA Sentinel Real World Evidence Data Enterprise (RWE‐DE)	3
Issue Information	3
Lack of Evidence for Vaccine‐Associated Enhanced Disease From COVID‐19 Vaccines Among Adults in the Vaccine Safety Datalink	3
Issue Information	3
Issue Information	3
Tying research question and analytical strategy when variables are affected by medication use	3
Comorbidity influence in observational studies: Why ignore the real world?	3
Stratified analysis in comparative effectiveness studies that emulate randomized trials	3
Nonsteroidal anti‐inflammatory drugs associated acute kidney injury in hospitalized children: A systematic review and meta‐analysis	3
Use of gastrointestinal prokinetics and the risk of parkinsonism: A population‐based case‐crossover study	3
The Impact of Hormone Replacement Therapy on the Risk of Heart Failure in Postmenopausal Women: A Meta‐Analysis of Clinical and Observational Studies	3
The most common medications dispensed to lactating persons: An electronic health record‐based approach	3
The impact of tightened prescribing restrictions on proton pump inhibitor use in Australia: An evaluation using interrupted time series analysis	3
Association between adherence to warfarin and thrombotic events in patients with antiphospholipid syndrome in Japan: A claims‐based retrospective cohort study	3